Albemarle (ALB) reported $1.08 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 20.9%. EPS of -$0.18 for the same period compares to $0.26 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.17 billion, representing a surprise of -8.07%. The company delivered an EPS surprise of +70.97%, with the consensus EPS estimate being -$0.62.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Albemarle performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Sales- Energy Storage: $524.57 million compared to the $588.57 million average estimate based on six analysts. The reported number represents a change of -34.5% year over year.
- Net Sales- Ketjen: $231.30 million versus $243.93 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -5.1% change.
- Net Sales- Specialties: $321.01 million versus the six-analyst average estimate of $329.98 million. The reported number represents a year-over-year change of +1.6%.
- Adjusted EBITDA- Energy Storage: $186.36 million versus $132.93 million estimated by six analysts on average.
- Adjusted EBITDA- Corporate: -$16.47 million compared to the -$9.39 million average estimate based on six analysts.
- Adjusted EBITDA- Ketjen: $38.59 million versus $27.55 million estimated by six analysts on average.
- Adjusted EBITDA- Specialties: $58.67 million versus the six-analyst average estimate of $55.43 million.
View all Key Company Metrics for Albemarle here>>>
Shares of Albemarle have returned -17.2% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Albemarle Corporation (ALB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
